Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders

Orphanet J Rare Dis. 2019 Jan 9;14(1):9. doi: 10.1186/s13023-018-0991-3.

Abstract

Background: Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax.

Results: Conservative treatment lead to a decline of chylothorax after mean of 66 days and consisted of the treatment of the underlying disease and of simultaneous long-term supportive care (drainage of the thoracic cavity, dietary measures and nutrition management). In most cases (80%), chylothorax disappeared only after a successful therapeutic response of the underlying disease. Low-dose radiotherapy had very good effects in two patients.

Conclusion: Conservative treatment of malignant chylothorax can be considered a suitable method. Based on our results, successful treatment of the lymphoproliferative disorder seems to be a very important factor for the disappearance of chylothorax.

Keywords: Chronic lymphocytic leukemia; Chylothorax; Non-Hodgkin′s lymphoma; Radiotherapy; Thoracic duct.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Chylothorax / drug therapy
  • Chylothorax / radiotherapy*
  • Chylothorax / therapy*
  • Female
  • Humans
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Lymphoid / radiotherapy
  • Leukemia, Lymphoid / therapy
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / radiotherapy
  • Lymphoma, Non-Hodgkin / therapy
  • Lymphoproliferative Disorders / drug therapy
  • Lymphoproliferative Disorders / radiotherapy*
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Thoracic Duct / drug effects
  • Thoracic Duct / radiation effects